RNF146
Basic information
Region (hg38): 6:127266726-127288567
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNF146 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 15 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 1 | 1 |
Variants in RNF146
This is a list of pathogenic ClinVar variants found in the RNF146 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-127286633-A-T | not specified | Uncertain significance (Aug 11, 2022) | ||
6-127286675-C-T | not specified | Uncertain significance (Dec 16, 2023) | ||
6-127286713-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
6-127286759-G-T | not specified | Uncertain significance (Mar 29, 2023) | ||
6-127286978-G-C | not specified | Uncertain significance (Sep 29, 2023) | ||
6-127287125-T-C | not specified | Uncertain significance (May 13, 2024) | ||
6-127287133-C-A | not specified | Uncertain significance (Sep 22, 2022) | ||
6-127287180-C-T | Likely benign (Jan 01, 2023) | |||
6-127287181-G-A | not specified | Uncertain significance (Nov 13, 2023) | ||
6-127287199-A-G | not specified | Uncertain significance (Nov 14, 2023) | ||
6-127287289-G-T | not specified | Uncertain significance (Oct 12, 2022) | ||
6-127287290-A-G | not specified | Uncertain significance (Jan 09, 2024) | ||
6-127287305-G-C | not specified | Uncertain significance (Mar 01, 2024) | ||
6-127287320-C-T | not specified | Uncertain significance (Jan 17, 2023) | ||
6-127287583-G-A | Benign (Mar 29, 2018) | |||
6-127287587-G-A | not specified | Uncertain significance (Dec 28, 2022) | ||
6-127287653-C-A | not specified | Uncertain significance (Apr 07, 2022) | ||
6-127287680-T-G | not specified | Uncertain significance (May 23, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RNF146 | protein_coding | protein_coding | ENST00000368314 | 2 | 21958 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.820 | 0.180 | 125505 | 0 | 9 | 125514 | 0.0000359 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.33 | 148 | 201 | 0.736 | 0.0000106 | 2311 |
Missense in Polyphen | 32 | 74.975 | 0.42681 | 856 | ||
Synonymous | 0.384 | 71 | 75.2 | 0.944 | 0.00000421 | 750 |
Loss of Function | 3.03 | 2 | 14.4 | 0.139 | 9.61e-7 | 155 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000627 | 0.0000616 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000356 | 0.0000353 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase that specifically binds poly-ADP-ribosylated (PARsylated) proteins and mediates their ubiquitination and subsequent degradation. May regulate many important biological processes, such as cell survival and DNA damage response. Acts as an activator of the Wnt signaling pathway by mediating the ubiquitination of PARsylated AXIN1 and AXIN2, 2 key components of the beta-catenin destruction complex. Acts in cooperation with tankyrase proteins (TNKS and TNKS2), which mediate PARsylation of target proteins AXIN1, AXIN2, BLZF1, CASC3, TNKS and TNKS2. Recognizes and binds tankyrase-dependent PARsylated proteins via its WWE domain and mediates their ubiquitination, leading to their degradation. Different ubiquitin linkage types have been observed: TNKS2 undergoes ubiquitination at 'Lys-48' and 'Lys-63', while AXIN1 is only ubiquitinated at 'Lys-48'. May regulate TNKS and TNKS2 subcellular location, preventing aggregation at a centrosomal location. Neuroprotective protein. Protects the brain against N-methyl-D-aspartate (NMDA) receptor-mediated glutamate excitotoxicity and ischemia, by interfering with PAR-induced cell death, called parthanatos. Prevents nuclear translocation of AIFM1 in a PAR-binding dependent manner. Does not affect PARP1 activation (By similarity). Protects against cell death induced by DNA damaging agents, such as N- methyl-N-nitro-N-nitrosoguanidine (MNNG) and rescues cells from G1 arrest. Promotes cell survival after gamma-irradiation. Facilitates DNA repair. {ECO:0000250, ECO:0000269|PubMed:21478859, ECO:0000269|PubMed:21602803, ECO:0000269|PubMed:21799911, ECO:0000269|PubMed:21825151, ECO:0000269|PubMed:22267412}.;
- Disease
- DISEASE: Note=Defects in RNF146 are a cause of susceptibility to breast cancer.;
- Pathway
- Signaling by WNT;Signal Transduction;Regulation of PTEN stability and activity;Post-translational protein modification;Metabolism of proteins;Ub-specific processing proteases;PTEN Regulation;PIP3 activates AKT signaling;Deubiquitination;Intracellular signaling by second messengers;TCF dependent signaling in response to WNT;Degradation of AXIN
(Consensus)
Recessive Scores
- pRec
- 0.0731
Intolerance Scores
- loftool
- 0.402
- rvis_EVS
- 0.15
- rvis_percentile_EVS
- 64.51
Haploinsufficiency Scores
- pHI
- 0.0571
- hipred
- Y
- hipred_score
- 0.591
- ghis
- 0.520
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rnf146
- Phenotype
- craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); limbs/digits/tail phenotype; skeleton phenotype; immune system phenotype; respiratory system phenotype;
Gene ontology
- Biological process
- ubiquitin-dependent protein catabolic process;Wnt signaling pathway;protein autoubiquitination;protein K48-linked ubiquitination;positive regulation of canonical Wnt signaling pathway
- Cellular component
- nucleoplasm;cytosol;plasma membrane
- Molecular function
- ubiquitin-protein transferase activity;protein binding;zinc ion binding;ubiquitin protein ligase activity;poly-ADP-D-ribose binding